阳谷华泰: 关于向深圳证券交易所申请恢复审核发行股份及支付现金购买资产并募集配套资金暨关联交易事项的公告

Group 1 - The company, Shandong Yanggu Huatai Chemical Co., Ltd., has submitted an application to the Shenzhen Stock Exchange for the review of its plan to issue shares and pay cash for asset acquisition, along with raising supporting funds [1][2] - The application was received by the Shenzhen Stock Exchange on May 29, 2025, and the company received an inquiry letter regarding the application on June 8, 2025 [1] - The company submitted a response report and other related documents to the Shenzhen Stock Exchange on June 28, 2025, updating the inquiry response [1] Group 2 - Due to necessary adjustments to the transaction plan, the Shenzhen Stock Exchange suspended the review process in accordance with the revised rules for major asset restructuring [2] - The company has completed the relevant work for adjusting the transaction plan and has submitted an application for the resumption of the review process to the Shenzhen Stock Exchange [2] - The company emphasizes that the transaction is subject to approval by the Shenzhen Stock Exchange and registration with the China Securities Regulatory Commission, indicating uncertainty regarding the approval timeline [2]